Varian Medical Systems (VAR) Misses Q4 EPS by 4c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Varian Reports Results for Fourth Quarter and Full Fiscal Year 2018
October 23, 2018 4:06 PM EDTPALO ALTO, Calif., Oct. 23, 2018 /PRNewswire/ --
Fourth Quarter 2018 Summary       Oncology gross orders grew 13% in dollars, or 14% in constant currency       84 Halcyon orders in the quarter       Total company revenues of $802 million grew 11%, or 12% in constant currency       GAAP operating earnings grew 29% at 16.8% of revenues; Non-GAAP operating earnings grew 14% at 17.8% of revenues       GAAP net earnings per diluted share from continuing operations of $1.26; Non-GAAP net earnings per diluted share from continuing operations of $1.16
Fiscal Year 2018 Summary       Oncology gross orders grew 9%, or 8% in constant currency       Added 224 linear accelerators to the installed base which is now greater than 8,000 units       Total company revenues of $2.9... More
